Search
for
Sort by
Research 241–270 of 1000+
- Dermatological problems of the puberty
- Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis
- The Intersection of Sleep and Hair Loss: A Systematic Review
- Synthesis and Actions of 5α-Reduced Metabolites of Testosterone in the Nervous System
- Health consequences of anabolic steroids: a sexual-medicine perspective
- Naturally Occurring Hair Growth Peptide: Water-Soluble Chicken Egg Yolk Peptides Stimulate Hair Growth Through Induction of Vascular Endothelial Growth Factor Production
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome
- Herbal Extracts Induce Dermal Papilla Cell Proliferation of Human Hair Follicles
- Paternal Finasteride Treatment Can Influence the Testicular Transcriptome Profile of Male Offspring—Preliminary Study
- Biology of Hair Growth and Influence of External Factors (Ecology, Stress, Nutrition
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Protective cardiovascular and renal actions of vitamin D and estrogen
- Interventional studies for polycystic ovarian syndrome in children and adolescents
- An overview of management of drug-induced hair and nail disorders
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- Safety of testosterone treatment in postmenopausal women
- Comparison of finasteride versus flutamide in the treatment of hirsutism
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Fadrozole and finasteride exposures modulate sex steroid- and thyroid hormone-related gene expression in Silurana (Xenopus) tropicalis early larval development
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Gender-Affirming Hormone Therapy for Transgender Men